Fortis Malar Hospitals Intrinsic Value
FORTISMLR Valuation Methods Summary
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹17.67 | ₹14.14 - ₹21.20 | -70.0% | EPS: ₹0.04, Sector P/E: 12x |
| Book Value Method | asset | ₹15.79 | ₹14.21 - ₹17.37 | -73.2% | Book Value/Share: ₹15.79, P/B: 1.0x |
| Revenue Multiple Method | revenue | ₹17.67 | ₹15.90 - ₹19.44 | -70.0% | Revenue/Share: ₹2.11, P/S: 0.8x |
| Simple DCF (5Y) | dcf | ₹23.56 | ₹18.85 - ₹28.27 | -60.0% | CF Growth: 5.0%, Discount: 15% |
| PEG Ratio Method | growth | ₹17.67 | ₹15.90 - ₹19.44 | -70.0% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹17.67 | ₹15.90 - ₹19.44 | -70.0% | Revenue Growth: 6.0%, Adj P/E: 8.2x |
| Graham Defensive Method | conservative | ₹17.67 | ₹15.90 - ₹19.44 | -70.0% | EPS: ₹0.04, BVPS: ₹15.79 |
Want to compare with current market value? Check FORTISMLR share price latest .
Valuation Comparison Chart
FORTISMLR Intrinsic Value Analysis
What is the intrinsic value of FORTISMLR?
Based on our comprehensive analysis using 7 different valuation methods, the estimated intrinsic value of Fortis Malar Hospitals (FORTISMLR) is ₹17.67 (median value). With the current market price of ₹58.91, this represents a -70.0% variance from our estimated fair value.
The valuation range spans from ₹15.79 to ₹23.56, indicating ₹15.79 - ₹23.56.
Is FORTISMLR undervalued or overvalued?
Based on our multi-method analysis, Fortis Malar Hospitals (FORTISMLR) appears to be trading above calculated value by approximately 70.0%.
Financial Health Analysis
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Debt to Equity Ratio | 1.23 | Industry Standard: <0.5 | Above 1.0 | Indicates financial leverage level |
| Operating Margin | -1233.0% | Industry Standard: 20%+ | Below 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.11x | Industry Standard: 1.0x+ | Below 0.5x | Measures asset utilization efficiency |
Related Pages for Fortis Malar Hospitals
Additional stock information and data for FORTISMLR
Cash Flow Quality Analysis
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹2 Cr | ₹-13 Cr | Positive Operating Cash Flow | 6/10 |
| March 2024 | ₹-7 Cr | ₹-7 Cr | Negative Cash Flow | 3/10 |
| March 2023 | ₹6 Cr | ₹6 Cr | Positive Free Cash Flow | 8/10 |
| March 2022 | ₹7 Cr | ₹7 Cr | Positive Free Cash Flow | 8/10 |
| March 2021 | ₹-1 Cr | ₹-15 Cr | Negative Cash Flow | 3/10 |